No Data
No Data
Earnings Call Summary | Atea Pharmaceuticals(AVIR.US) Q1 2024 Earnings Conference
The following is a summary of the Atea Pharmaceuticals, Inc. (AVIR) Q1 2024 Earnings Call Transcript:Financial Performance:Atea Pharmaceuticals Inc. ended Q1 2024 with a cash equivalent and marketable
Express News | Atea Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $4 From $5
Atea Pharmaceuticals | 10-Q: Quarterly report
Express News | Atea Pharmaceuticals Inc: Qtrly Shr Loss $0.75
Express News | Atea Pharmaceuticals Q1 2024 GAAP EPS $(0.75) Misses $(0.61) Estimate
Atea Pharmaceuticals 1Q Loss/Shr 75c >AVIR
Atea Pharmaceuticals 1Q Loss/Shr 75c >AVIR
No Data